Welcome to LookChem.com Sign In|Join Free
  • or
4-Pentynoic acid, 5-[4-(trifluoromethyl)phenyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

876049-26-2

Post Buying Request

876049-26-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

876049-26-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 876049-26-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,0,4 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 876049-26:
(8*8)+(7*7)+(6*6)+(5*0)+(4*4)+(3*9)+(2*2)+(1*6)=202
202 % 10 = 2
So 876049-26-2 is a valid CAS Registry Number.

876049-26-2Relevant academic research and scientific papers

Cycloisomerization of acetylenic acids to γ-alkylidene lactones using a palladium(II) catalyst supported on amino-functionalized siliceous mesocellular foam

Nagendiran, Anuja,Verho, Oscar,Haller, Clemence,Johnston, Eric V.,Baeckvall, Jan-E.

, p. 1399 - 1405 (2014)

Cycloisomerization of various γ-acetylenic acids to their corresponding γ-alkylidene lactones by the use of a heterogeneous Pd(II) catalyst supported on amino-functionalized siliceous mesocellular foam is described. Substrates containing terminal as well

An effective synthetic entry to fused benzimidazoles via iodocyclization

Zhang, Xu,Zhou, Yu,Wang, Hengshuai,Guo, Diliang,Ye, Deju,Xu, Yungen,Jiang, Hualiang,Liu, Hong

, p. 1429 - 1437 (2011/08/03)

A protocol for the synthesis of the fused heterocyclic polycyclic compounds pyrrole[1,2-a]benzimidazoles, piperidine[1,2-a]benzimidazoles and oxa-fused benzimidazoles using iodine and silver nitrate by an exo-dig or endo-dig cyclization pathway at room te

Indole derivatives comprising an acetylene group

-

Page/Page column 26, (2008/06/13)

This invention is directed to compounds of the formula (I): wherein one of R6, R7, R8 and R9 is and X, R1 to R12, m, n and o are as defined in the description, and pharmaceutically acceptable salts and/or esters thereof. The invention is also directed to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARδ and/or PPARα agonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 876049-26-2